Sumioka Isao, Matsura Tatsuya, Kai Masachika, Yamada Kazuo
Healthcare Research Institute, Wakunaga Pharmaceutical Co., Ltd., 1624 Shimokotachi, Koda-cho, Takata-gun, Hiroshima 739-1195, Japan.
Life Sci. 2004 Apr 2;74(20):2551-61. doi: 10.1016/j.lfs.2003.10.011.
The aim of the present study was to assess the contribution of the level of expression of heat shock protein 25 (HSP25), 60 (HSP60), 70 (HSC70) and 70i (HSP70i) in mouse livers after a lethal dose of acetaminophen (APAP) to their survival. We examined changes in survival ratio, plasma APAP level and alanine aminotransferase (ALT) activity, and hepatic reduced glutathione (GSH), HSP25, HSP60, HSC70 and HSP70i levels following treatment of mice with APAP (500 mg/kg, p.o.). The plasma APAP level increased rapidly, and reached a maximum 0.5 h after APAP treatment. Hepatic GSH decreased rapidly, and was almost completely depleted 1 h after APAP treatment. Plasma ALT activity, an index of liver injury, significantly increased from 3 h onwards after APAP treatment. The survival ratios 9 h, 24 h and 48 h after APAP treatment were 96%, 38% and 36%, respectively. We found a remarkable difference in the patterns of hepatic HSP25 and HSP70i induction in mice that survived after APAP treatment. HSP70i levels increased from 1 h onwards after APAP treatment in a time-dependent manner, and reached a maximum at 9 h. In contrast, HSP25 could be detected just 24 h after APAP treatment, and maximal accumulation was observed at 48 h. Other HSPs examined were unchanged. Notably, the survival ratio dropped by only 2% after HSP25 expression. Recently, a novel role for HSP25 as an anti-inflammatory factor was suggested. We have already shown that 48-h treatment with APAP induces severe centrilobular necrosis with inflammatory cell infiltration in mouse livers. Taken together, the level of expression of hepatic HSP25 may be a crucial determinant of the fate of mice exposed to APAP insult.
本研究的目的是评估在给予小鼠致死剂量的对乙酰氨基酚(APAP)后,小鼠肝脏中热休克蛋白25(HSP25)、60(HSP60)、70(HSC70)和70i(HSP70i)的表达水平对其存活的影响。在用APAP(500 mg/kg,口服)处理小鼠后,我们检测了存活率、血浆APAP水平、丙氨酸转氨酶(ALT)活性以及肝脏中还原型谷胱甘肽(GSH)、HSP25、HSP60、HSC70和HSP70i的水平变化。血浆APAP水平迅速升高,在APAP处理后0.5小时达到峰值。肝脏GSH迅速下降,在APAP处理后1小时几乎完全耗尽。作为肝损伤指标的血浆ALT活性在APAP处理后3小时起显著升高。APAP处理后9小时、24小时和48小时的存活率分别为96%、38%和36%。我们发现,在APAP处理后存活的小鼠中,肝脏HSP25和HSP70i的诱导模式存在显著差异。APAP处理后1小时起,HSP70i水平呈时间依赖性升高,并在9小时达到峰值。相比之下,HSP25在APAP处理后24小时才能够被检测到,并且在48小时观察到最大积累。所检测的其他热休克蛋白没有变化。值得注意的是,HSP25表达后存活率仅下降2%。最近,有人提出HSP25作为一种抗炎因子具有新的作用。我们已经表明,用APAP处理48小时会诱导小鼠肝脏出现严重的小叶中心坏死并伴有炎症细胞浸润。综上所述,肝脏HSP25的表达水平可能是暴露于APAP损伤的小鼠命运的关键决定因素。